OmniAb (OABI) Competitors $3.38 -0.04 (-1.02%) As of 02:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends OABI vs. RAMP, APLD, ASTH, GDRX, STGW, QBTS, PINC, SEZL, PHR, and DGNXShould you be buying OmniAb stock or one of its competitors? The main competitors of OmniAb include LiveRamp (RAMP), Applied Digital (APLD), Astrana Health (ASTH), GoodRx (GDRX), Stagwell (STGW), D-Wave Quantum (QBTS), Premier (PINC), Sezzle (SEZL), Phreesia (PHR), and Diginex (DGNX). These companies are all part of the "business services" industry. OmniAb vs. LiveRamp Applied Digital Astrana Health GoodRx Stagwell D-Wave Quantum Premier Sezzle Phreesia Diginex LiveRamp (NYSE:RAMP) and OmniAb (NASDAQ:OABI) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, community ranking, valuation, risk and institutional ownership. Is RAMP or OABI more profitable? LiveRamp has a net margin of 0.01% compared to OmniAb's net margin of -308.78%. LiveRamp's return on equity of 0.97% beat OmniAb's return on equity.Company Net Margins Return on Equity Return on Assets LiveRamp0.01% 0.97% 0.75% OmniAb -308.78%-20.97%-18.05% Does the MarketBeat Community prefer RAMP or OABI? LiveRamp received 147 more outperform votes than OmniAb when rated by MarketBeat users. However, 100.00% of users gave OmniAb an outperform vote while only 70.25% of users gave LiveRamp an outperform vote. CompanyUnderperformOutperformLiveRampOutperform Votes17070.25% Underperform Votes7229.75% OmniAbOutperform Votes23100.00% Underperform VotesNo Votes Do insiders and institutionals have more ownership in RAMP or OABI? 93.8% of LiveRamp shares are held by institutional investors. Comparatively, 72.1% of OmniAb shares are held by institutional investors. 3.4% of LiveRamp shares are held by company insiders. Comparatively, 8.6% of OmniAb shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, RAMP or OABI? LiveRamp has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, OmniAb has a beta of -0.12, suggesting that its share price is 112% less volatile than the S&P 500. Does the media prefer RAMP or OABI? In the previous week, LiveRamp had 6 more articles in the media than OmniAb. MarketBeat recorded 7 mentions for LiveRamp and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.89 beat LiveRamp's score of 0.48 indicating that OmniAb is being referred to more favorably in the news media. Company Overall Sentiment LiveRamp Neutral OmniAb Very Positive Do analysts rate RAMP or OABI? LiveRamp currently has a consensus price target of $39.83, suggesting a potential upside of 36.60%. OmniAb has a consensus price target of $9.00, suggesting a potential upside of 167.46%. Given OmniAb's stronger consensus rating and higher probable upside, analysts plainly believe OmniAb is more favorable than LiveRamp.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LiveRamp 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67OmniAb 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, RAMP or OABI? LiveRamp has higher revenue and earnings than OmniAb. OmniAb is trading at a lower price-to-earnings ratio than LiveRamp, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiveRamp$728.71M2.63$11.88M$0.012,916.10OmniAb$20.41M23.28-$50.62M-$0.62-5.43 SummaryLiveRamp beats OmniAb on 11 of the 17 factors compared between the two stocks. Get OmniAb News Delivered to You Automatically Sign up to receive the latest news and ratings for OABI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OABI vs. The Competition Export to ExcelMetricOmniAbCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$475.19M$3.65B$5.81B$8.32BDividend YieldN/A2.03%4.76%3.97%P/E Ratio-5.43109.9024.8719.01Price / Sales23.28223.13374.09109.96Price / CashN/A34.5738.0534.62Price / Book1.252.737.234.20Net Income-$50.62M$113.28M$3.19B$246.79M7 Day Performance-6.27%-10.65%-3.99%-4.74%1 Month Performance1.66%-6.67%-7.81%-7.84%1 Year Performance-40.34%-5.93%11.49%2.38% OmniAb Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OABIOmniAb2.1102 of 5 stars$3.39-1.0%$9.00+165.9%-42.1%$478.02M$20.41M-5.467Positive NewsRAMPLiveRamp4.4701 of 5 stars$30.87-1.2%$39.33+27.4%-13.8%$2.03B$728.71M3,086.501,400APLDApplied Digital3.8533 of 5 stars$9.02-15.3%$12.11+34.3%+63.4%$2.01B$165.57M-5.21121ASTHAstrana Health3.8841 of 5 stars$34.59-3.1%$63.00+82.1%-39.2%$1.95B$1.72B26.611,800Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGDRXGoodRx3.3792 of 5 stars$4.84+0.6%$8.38+73.0%-41.9%$1.84B$750.27M-161.33950Gap DownHigh Trading VolumeSTGWStagwell2.3685 of 5 stars$6.66+5.7%$8.58+28.9%+13.6%$1.75B$2.53B20.5013,000QBTSD-Wave Quantum2.4176 of 5 stars$6.41-11.6%$6.71+4.7%+184.9%$1.73B$8.76M-15.263Gap DownPINCPremier3.098 of 5 stars$18.51-0.5%$20.50+10.8%-14.0%$1.69B$1.29B-185.082,900Positive NewsSEZLSezzle4.1921 of 5 stars$284.22-0.8%$366.00+28.8%+503.9%$1.59B$221.81M30.24540Earnings ReportGap DownPHRPhreesia3.1116 of 5 stars$27.15-3.8%$31.15+14.8%+3.3%$1.58B$405.14M-18.471,438Gap DownDGNXDiginexN/A$69.34+38.7%N/AN/A$1.57BN/A0.0021Quiet Period ExpirationGap Down Related Companies and Tools Related Companies LiveRamp Alternatives Applied Digital Alternatives Astrana Health Alternatives GoodRx Alternatives Stagwell Alternatives D-Wave Quantum Alternatives Premier Alternatives Sezzle Alternatives Phreesia Alternatives Diginex Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OABI) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredWhy 2026 will be a disaster for many AmericansWall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OmniAb, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OmniAb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.